Recent Lessons

Show all results for ""

Feature Overview

Ace your exams with our all-in-one platform for creating and sharing quizzes and tests.

Quizzes

Create quizzes and tests automatically from your content using AI.

Flashcards

Automatically turn your notes into digital flashcards.

Share, Export & Embed

Share with classmates or export to Excel and your learning management system.

Stats & Reporting

Auto-grading quizzes and tests with detailed stats and reports.

Mobile Apps

The smarter way to study – wherever you are.

Pricing

Search...

Test your knowledge on EGFR mutation-guided treatments for lung cancer

9 Questions

0 Views

Test your knowledge on EGFR mutation-guided treatments for lung cancer

Choose a study mode

Play Quiz

Study Flashcards

Spaced Repetition

Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the most common form of lung cancer?

Non-small-cell lung cancer (NSCLC).

What drugs were tested for viability of cells expressing EGFR mutant?

Afatinib, erlotinib, and gefitinib.

What type of cancer did the patient present symptoms of?

Non-small cell lung cancer (NSCLC).

What is the significance of an epidermal growth factor (EGFR) mutation in NSCLC?

An EGFR mutation affects cell proliferation and sensitivity to available targeted therapies. Signup and view all the answers

What was the less expensive treatment option according to the study?

EGFR mutation-guided erlotinib. Signup and view all the answers

What is the significance of the EGFR mutation identified in the patient?

The EGFR mutation may make the patient more susceptible to EGFR inhibitors like erlotinib, gefitinib, and afatinib, which can be used as targeted therapies to treat the cancer. Signup and view all the answers

What analysis was used to compare base-case costs and QALYs?

ICER analysis. Signup and view all the answers

How do certain proteins influence tumour growth in relation to the EGFR mutation?

Through analysis, downregulation and upregulation of certain proteins (p21, cyclin D1 and IκBα) influences tumour growth in relation to the EGFR mutation. Signup and view all the answers

Why is molecular profiling important in treating NSCLC?

Molecular profiling helps guide potential personalized treatment options for the patient based on the specific mutations present in the cancer cells. Signup and view all the answers

Study Notes

Viability of cells expressing EGFR mutant was tested with different drugs.
EGFR mutation-guided use of afatinib, erlotinib, and gefitinib resulted in higher QALYs.
Cisplatin-pemetrexed chemotherapy was used as empirical treatment without EGFR mutation testing.
EGFR mutation-guided erlotinib was the less expensive treatment option.
EGFR mutation-guided afatinib and gefitinib were more expensive than empirical chemotherapy.
EGFR mutation-guided erlotinib was the preferred strategy from the viewpoint of the public healthcare provider in Hong Kong.
ICER analysis was used to compare base-case costs and QALYs.
EGFR mutation-guided erlotinib obtained greater QALYs with cost savings as compared with empirical chemotherapy.
Probabilistic sensitivity analysis validated the base-case findings.
IC50 value for the drug was 0.2901, indicating higher effectiveness.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Description

Think you know about EGFR mutation-guided treatments for non-small cell lung cancer? Test your knowledge with this quiz! From different drug viabilities to cost-effective treatment options, this quiz covers various aspects of EGFR mutation-guided treatments. Keywords include EGFR mutation, afatinib, erlotinib, gefitinib, chemotherapy, QALYs, ICER analysis, and sensitivity analysis.